|
2017
|
Invention
|
Potentiation of anticancer agents.
The present invention relates to carriers, conjugate and phar... |
|
|
Invention
|
Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof.
The ... |
|
2016
|
Invention
|
Etoposide and doxorubicin conjugates for drug delivery.
The invention relates to improvements in... |
|
|
Invention
|
Methods for the treatment of leptomeningeal carcinomatosis. The present invention features a meth... |
|
|
Invention
|
Delivery of antibodies to the central nervous system.
The invention relates to improvements in t... |
|
2015
|
Invention
|
Targeted α-l-iduronidase conjugates and uses thereof. The present invention is related to a compo... |
|
|
Invention
|
Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, an... |
|
|
Invention
|
Peptide therapeutic conjugates and uses thereof.
The present invention features a compound havin... |
|
|
Invention
|
Compositions and methods for the transport of therapeutic agents.
The present invention is direc... |
|
|
Invention
|
Potentiation of anticancer agents. The present invention relates to carriers, conjugate and pharm... |
|
2014
|
Invention
|
Aprotinin polypeptides for transporting a compound across the blood-brain barrier.
The invention... |
|
|
Invention
|
Targeted enzyme compounds and uses thereof. The present invention is related to the one-step synt... |
|
|
Invention
|
Targeted iduronate-2-sulfatase fusion proteins. The present invention is directed to polypeptides... |
|
|
Invention
|
Targeted heparan sulfatase compounds. The present invention is related to a compound that include... |
|
2013
|
Invention
|
Targeted iduronate-2-sulfatase compounds. The present invention is related to a compound that inc... |
|
|
Invention
|
Aprotinin-derived polypeptide-antibody conjugates.
The present invention relates to protein conj... |
|
|
Invention
|
Aprotinin-derived polypeptide-antibody conjugates. The present invention relates to protein conju... |
|
|
Invention
|
Peptide-dendrimer conjugates and uses thereof. The invention relates to dendrimers conjugated to ... |
|
|
Invention
|
Targeted enzyme compounds and uses thereof.
The present invention is related to a compound that ... |
|
|
Invention
|
Targeted iduronidase compounds. The present invention is related to a compound that includes (a) ... |
|
2012
|
Invention
|
Targeted lysosomal enzyme compounds.
The present invention is related to a compound that include... |
|
|
Invention
|
Targeted iduronate-2-sulfatase compounds.
The present invention is related to a compound that in... |
|
|
Invention
|
Targeted lysosomal enzyme compounds. The present invention is related to a compound that includes... |
|
|
Invention
|
Polypeptide-opioid conjugates and uses thereof. The invention features polypeptide-opioid conjuga... |
|
2011
|
Invention
|
Therapeutic polypeptides and uses thereof. The present invention relates to therapeutic polypepti... |
|
|
Invention
|
Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof. The p... |
|
|
Invention
|
Leptin and leptin analog conjugates and fusion proteins and uses thereof. The present invention f... |
|
|
Invention
|
Aprotinin polypeptides for transporting a compound across the blood-brain barrier. The invention ... |
|
2010
|
Invention
|
Compositions and methods for the transport of therapeutic agents. The present invention is direct... |
|
|
Invention
|
Multimeric peptide conjugates and uses thereof. The present invention relates to multimeric (e.g.... |
|
|
Invention
|
Fusion proteins for delivery of gdnf and bdnf to the central nervous system.
The present inventi... |
|
|
Invention
|
Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog. Ovarian... |
|
2009
|
Invention
|
Membrane type-1 matrix metalloprotein inhibitors and uses thereof. Based on the discovery that a ... |
|
|
Invention
|
Leptin and leptin analog conjugates and uses thereof.
The present invention features a compound ... |
|
|
Invention
|
Etoposide and doxorubicin conjugates for drug delivery. The invention relates to improvements in ... |
|
|
Invention
|
Conjugates of glp-1 agonists and uses thereof. The present invention features a compound having t... |
|
|
Invention
|
Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and relate... |
|
2007
|
Invention
|
Compounds for stimulating p-glycoprotein function and uses thereof. The present invention is dire... |
